Noninvasive imaging of atheromatous carotid plaques

Nature Clinical Practice Cardiovascular Medicine

Volumn 6, Issue 3, 2009, Pages 200-209

  Sadat, Umar ^a   Li, Zhi Yong ^b   Graves, Martin J ^b   Tang, Tjun Y ^b   Gillard, Jonathan H ^b  

^a Cambridge Archaeological Unit   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLUORODEOXYGLUCOSE F 18; GADOBENIC ACID; GADODIAMIDE; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; GADOVERSETAMIDE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANGIOGENESIS; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG SAFETY; DRUG WITHDRAWAL; HISTOPATHOLOGY; HUMAN; IMAGE QUALITY; INFLAMMATION; INTERMETHOD COMPARISON; KIDNEY FIBROSIS; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; THROMBOCYTE;

ANGIOGRAPHY; CAROTID ARTERY DISEASES; CAROTID ARTERY, INTERNAL; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 61449209910     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio1455     Document Type: Review

References (79)

1. Bush RL et al. (2005) Natural history of cerebrovascular occlusive disease. In Mastery of Vascular and Endovascular Surgery, edn 4 197-202 (Eds Zelenock GB et al.) Philadelphia: Lippincott Williams and Wilkins
2. Ross R (1999) Atherosclerosis is an inflammatory disease. Am Heart J 138: S419-S420
3. Schönbeck U and Libby P (2001) The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 58: 4-43
4. Hansson GK (2001) Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 21: 1876-1890
5. Libby P et al. (2002) Inflammation and atherosclerosis. Circulation 105: 1135-1143
6. Croce K and Libby P (2007) Intertwining of thrombosis and inflammation in atherosclerosis. Curr Opin Hematol 14: 55-61
7. Mach F et al. (1998) CD40 signaling in vascular cells: A key role in atherosclerosis? Atherosclerosis 137 (Suppl): S89-S95
8. Bayer IM et al. (2002) Experimental angiogenesis of arterial vasa vasorum. Cell Tissue Res 307: 303-313
9. Ribatti D et al. (2008) Inflammatory angiogenesis in atherogenesis - a double-edged sword. Ann Med 40: 606-621
10. Libby P (2002) Inflammation in atherosclerosis. Nature 420: 868-874
11. Li ZY et al. (2006) How critical is fibrous cap thickness to carotid plaque stability? A flow-plaque interaction model. Stroke 37: 1195-1199
12. Li ZY et al. (2006) Stress analysis of carotid plaque rupture based on in vivo high resolution MRI. J Biomech 39: 2611-2622
13. Davies PF (1995) Flow-mediated endothelial mechanotransduction. Physiol Rev 75: 519-560
14. Davies PF et al. (1997) Spatial relationships in early signaling events of flow-mediated endothelial mechanotransduction. Annu Rev Physiol 59: 527-549
15. Reneman RS et al. (2006) Wall shear stress-an important determinant of endothelial cell function and structure-in the arterial system in vivo. Discrepancies with theory. J Vasc Res 43 251-269
16. Reneman RS and Hoeks AP (2008) Wall shear stress as measured in vivo consequences for the design of the arterial system. Med Biol Eng Comput 46: 499-507
17. Cheng C et al. (2007) Shear stress-induced changes in atherosclerotic plaque composition are modulated by chemokines. J Clin Invest 117: 616-626
18. Slager CJ et al. (2005) The role of shear stress in the generation of rupture-prone vulnerable plaques. Nat Clin Pract Cardiovasc Med 2: 401-407
19. Slager CJ et al. (2005) The role of shear stress in the destabilization of vulnerable plaques and related therapeutic implications. Nat Clin Pract Cardiovasc Med 2: 456-464
20. Huang H et al. (2001) The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation 103: 1051-1056
21. Doriot PA and Dorsaz PA (2005) Estimation of the axial wall strains induced by an arterial stenosis at peak flow. Med Phys 32: 360-368
22. Li ZY and Gillard JH (2008) Plaque rupture: Plaque stress, shear stress, and pressure drop. J Am Coll Cardiol 52: 1106-1107
23. Spagnoli LG et al. (2004) Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 292 1845-1852
24. Altaf N et al. (2007) Carotid intraplaque hemorrhage predicts recurrent symptoms in patients with highgrade carotid stenosis. Stroke 38: 1633-1635
25. Altaf N et al. (2008) Detection of intraplaque hemorrhage by magnetic resonance imaging in symptomatic patients with mild to moderate carotid stenosis predicts recurrent neurological events. J Vasc Surg 47: 337-342
26. Takaya N et al. (2006) Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: A prospective assessment with MRI-initial results. Stroke 37: 818-823
27. Weinberger J et al. (1988) Morphologic and dynamic changes of atherosclerotic plaque at the carotid artery bifurcation: Sequential imaging by real time B-mode ultrasonography. J Am Coll Cardiol 12: 1515-1521
28. Glagov S et al. (1987) Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316: 1371-1375
29. Topol EJ and Nissen SE (1995) Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 92: 2333-2342
30. Fuster V et al. (2005) Atherothrombosis and high-risk plaque: Part II: Approaches by noninvasive computed tomographic/magnetic resonance imaging. J Am Coll Cardiol 46: 1209-1218
31. Fayad ZA and Fuster V (2008) Prologue: Relevance of molecular imaging in clinical medicine. Nat Clin Pract Cardiovasc Med 5 (suppl 2) S1
32. Saam T et al. (2007) The vulnerable, or high-risk, atherosclerotic plaque: Noninvasive MR imaging for characterization and assessment. Radiology 244: 64-77
33. Cai JM et al. (2002) Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation 106: 1368-1373
34. Hatsukami TS et al. (2000) Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 102: 959-964
35. Sanz J and Fayad ZA (2008) Imaging of atherosclerotic cardiovascular disease. Nature 451: 953-957
36. Rudd JH and Fayad ZA (2008) Imaging atherosclerotic plaque inflammation. Nat Clin Pract Cardiovasc Med 5 (suppl 2): S11-S17
37. Trivedi RA et al. (2004) MRI-derived measurements of fibrous-cap and lipid-core thickness: The potential for identifying vulnerable carotid plaques in vivo. Neuroradiology 46: 738-743
38. Moody AR et al. (1999) Direct magnetic resonance imaging of carotid artery thrombus in acute stroke. Lancet 353: 122-123
39. Chu B et al. (2004) Hemorrhage in the atherosclerotic plaque: A high-resolution MRI study. Stroke 35: 1079-1084
40. Rothwell PM et al. (2007) Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): A prospective population-based sequential comparison. Lancet 370: 1432-1442
41. Toussaint JF et al. (1997) Water diffusion properties of human atherosclerosis and thrombosis measured by pulse field gradient nuclear magnetic resonance. Arterioscler Thromb Vasc Biol 17: 542-546
42. Qiao Y et al. (2007) Identification of atherosclerotic lipid deposits by diffusion-weighted imaging. Arterioscler Thromb Vasc Biol 27: 1440-1446
43. Redgrave JN et al. (2008) Critical cap thickness and rupture in symptomatic carotid plaques: The oxford plaque study. Stroke 39 1722-1729
44. von zur Muhlen C et al. (2008) Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis. Circulation 118 258-267
45. Wasserman BA et al. (2002) Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results. Radiology 223: 566-573
46. Cai J et al. (2005) In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: Comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 112: 3437-3444
47. Kerwin W et al. (2003) Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 107: 851-856
48. Kerwin WS et al. (2006) Inflammation in carotid atherosclerotic plaque: A dynamic contrast-enhanced MR imaging study. Radiology 241: 459-468
49. Grobner T (2006) Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21: 1104-1108
50. Kimura J et al. (2005) Human comparative study of zinc and copper excretion via urine after administration of magnetic resonance imaging contrast agents. Radiat Med 23: 322-326
51. Dawson P (2008) Nephrogenic systemic fibrosis: Possible mechanisms and imaging management strategies. J Magn Reson Imaging 28: 797-804
52. Agarwal R et al. (2008) Gadolinium-based contrast agents and nephrogenic systemic fibrosis: A systematic review and meta-analysis. Nephrol Dial Transplant [doi:10.1093/ndt/gfn593]
53. Nagaoka K et al. (2005) Association of SIGNR1 with TLR4-MD-2 enhances signal transduction by recognition of LPS in gram-negative bacteria. Int Immunol 17: 827-836
54. Bonnemain B (1998) Superparamagnetic agents in magnetic resonance imaging: Physicochemical characteristics and clinical applications. A review. J Drug Target 6: 167-174
55. Di Marco M et al. (2007) Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents. Int J Nanomedicine 2: 609-622
56. Crowe LA et al. (2005) Ex vivo MR imaging of atherosclerotic rabbit aorta labelled with USPIO-enhancement of iron-loaded regions in UTE imaging. Proc Intl Soc Mag Reson Med 13: 115
57. Howarth SP et al. (2008) Utility of USPIO-enhanced MR imaging to identify inflammation and the fibrous cap: A comparison of symptomatic and asymptomatic individuals. Eur J Radiol [doi:10.1016/ j.ejrad.2008.01.047]
58. Trivedi RA et al. (2004) In vivo detection of macrophages in human carotid atheroma: Temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 35: 1631-1635
59. Tang T et al. (2006) Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 37: 2266-2270
60. Tang TY et al. (2008) Correlation of carotid atheromatous plaque inflammation with biomechanical stress: Utility of USPIO enhanced MR imaging and finite element analysis. Atherosclerosis 196: 879-887
61. Tang TY et al. (2008) Effects of aggressive versus conventional lipid-lowering therapy by atorvastatin on inflammatory activity in human carotid atherosclerotic plaques: A prospective randomised double-blind trial with USPIO-enhanced high resolution magnetic resonance imaging. Abstract 409-6. Presented at the American College of Cardiology Scientific Sessions: 2008 March 29 to April 1, Chicago, IL, USA.
62. Cheng GC et al. (1993) Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation. Circulation 87: 1179-1187
63. Tang D et al. (2004) 3D MRI-based multicomponent FSI models for atherosclerotic plaques. Ann Biomed Eng 32: 947-960
64. Morrisett J et al. (2003) Discrimination of components in atherosclerotic plaques from human carotid endarterectomy specimens by magnetic resonance imaging ex vivo. Magn Reson Imaging 21: 465-474
65. Estes JM et al. (1998) Noninvasive characterization of plaque morphology using helical computed tomography. J Cardiovasc Surg (Torino) 39: 527-534
66. Oliver TB et al. (1999) Atherosclerotic plaque at the carotid bifurcation: CT angiographic appearance with histopathologic correlation. AJNR Am J Neuroradiol 20: 897-901
67. Walker LJ et al. (2002) Computed tomography angiography for the evaluation of carotid atherosclerotic plaque: Correlation with histopathology of endarterectomy specimens. Stroke 33: 977-981
68. de Weert TT et al. (2008) Assessment of atherosclerotic carotid plaque volume with multidetector computed tomography angiography. Int J Cardiovasc Imaging 24: 751-759
69. Hyafil F et al. (2007) Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med 13: 636-641
70. Matsumoto M et al. (2007) Dynamic 3D-CT angiography. AJNR Am J Neuroradiol 28: 299-304
71. Vallabhajosula S and Fuster V (1997) Atherosclerosis: Imaging techniques and the evolving role of nuclear medicine. J Nucl Med 38: 1788-1796
72. Bleeker-Rovers CP et al. (2003) F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 61: 323-329
73. Meller J et al. (2003) Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 30: 730-736
74. Rudd JH et al. (2002) Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105: 2708-2711
75. Davies JR et al. (2005) Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 36: 2642-2647
76. Calcagno C et al. (2008) Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET. Arterioscler Thromb Vasc Biol 28: 1311-1317
77. Rudd JH et al. (2007) (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: Implications for atherosclerosis therapy trials. J Am Coll Cardiol 50: 892-896
78. Rudd JH et al. (2008) Atherosclerosis inflammation imaging with 18F-FDG PET: Carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med 49: 871-878
79. Tang TY et al. (2008) Combined PET-FDG and USPIO-enhanced MR imaging in patients with symptomatic moderate carotid artery stenosis. Eur J Vasc Endovasc Surg 36: 53-55